Editorial
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Sep 7, 2024; 30(33): 3799-3802
Published online Sep 7, 2024. doi: 10.3748/wjg.v30.i33.3799
Lipid metabolism-related long noncoding RNAs: A potential prognostic biomarker for hepatocellular carcinoma
Rui-Nan Zhang, Jian-Gao Fan
Rui-Nan Zhang, Jian-Gao Fan, Department of Gastroenterology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China
Author contributions: Fan JG designed the overall concept and outlined the manuscript; Zhang RN reviewed the literature, wrote and edited the manuscript; Both authors have read and approved the final version to be published.
Supported by National Natural Science Foundation of China, No. 82170593, No. 81700503; and the National Key Research and Development Program of China, No. 2021YFC2700802.
Conflict-of-interest statement: All the authors have nothing to disclose.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Jian-Gao Fan, MD, PhD, Director, Professor, Department of Gastroenterology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, No. 1665 Kongjiang Road, Shanghai 200092, China. fanjiangao@xinhuamed.com.cn
Received: March 26, 2024
Revised: August 13, 2024
Accepted: August 16, 2024
Published online: September 7, 2024
Processing time: 158 Days and 9.8 Hours
Core Tip

Core Tip: Lipid metabolism and long noncoding RNAs (lncRNAs) are pivotal in hepatocellular carcinoma (HCC) development. While the prognosis of HCC remains poor and prognostic biomarkers are lacking, lipid metabolism-related lncRNAs may be promising candidates for prognostic biomarkers in HCC.